À retenir
After wearing a waist-worn sensor for a week, 106 participants rated it comfortable (median Comfort Rating Scale 0.0 on a 0-20 scale where lower is better) and acceptable (median 5.0 on a 1-5 scale where higher is better). This reports comfort and opinion, not measurement accuracy, and the abstract does not describe who the participants were.
Study design
Validation : étude/revue
Reading basis
Published abstract
Reading focus
Reference & error
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Measuring mobility at home with a wearable only works if people are willing to wear it. The authors examined how acceptable a waist-worn device was in the Mobilise-D technical validation study, and what participants thought about using digital tools to monitor their health.
Population et méthode
Participants (N = 106) in the Mobilise-D technical validation study wore a waist-worn McRoberts Dynaport MM+ for one week. They then completed two questionnaires, the Comfort Rating Scale (CRS) and a previously validated acceptability questionnaire. A subset (n = 36) also took part in semi-structured interviews about device acceptability and views on digital health monitoring. Questionnaires were analysed descriptively and interviews with content analysis. The abstract does not describe the participants' ages or conditions.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1The device was rated comfortable: median CRS 0.0 (IQR 0.0; range 0-20) on a 0-20 scale where lower means better comfort.
- 2It was rated acceptable: median 5.0 (IQR 0.5; range 3.0-5.0) on a 1-5 scale where higher means better acceptability.
- 3In interviews, participants found it easy to use, comfortable, and not disruptive to daily activities.
- 4Themes important to digital technology were altered expectations for themselves, the use of technology, trust, and communication with healthcare professionals.
Limites et incertitude
- 1Median scores sitting at or near the best possible value suggest a ceiling effect, which leaves little room to detect differences between people.
- 2Only 36 of the 106 participants were interviewed, and the abstract does not say how they were chosen, so the themes may not represent everyone.
- 3Participants had just completed a technical validation study and wore the device for one week, so willingness to wear it for months in daily life remains untested.
- 4The authors say further work with patient advisors is needed to understand key issues raised. This reading is based on the abstract only.
Mise en perspective
People in this study did not find a waist-worn mobility sensor a burden over a week, which supports using such devices for remote monitoring in research and care. It does not tell you whether the device measures walking accurately. Any decision about monitoring your health should involve your clinician.
Vos données
If you track your own walking with a phone or waist or wrist device, comfort and consistent wear matter as much as the sensor, because gaps in wear make weekly totals unreliable. Wear it the same way on the same days and compare your own weeks.
Comprendre ce type de preuve
Agreement is specific to the device, firmware, reference, population and setting. Correlation is not agreement, and validating a metric is not proof of diagnostic or treatment benefit.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
This study aimed to explore the acceptability of a wearable device for remotely measuring mobility in the Mobilise-D technical validation study (TVS), and to explore the acceptability of using digital tools to monitor health.
Methods
Participants ( N = 106) in the TVS wore a waist-worn device (McRoberts Dynaport MM + ) for one week. Following this, acceptability of the device was measured using two questionnaires: The Comfort Rating Scale (CRS) and a previously validated questionnaire. A subset of participants ( n = 36) also completed semi-structured interviews to further determine device acceptability and to explore their opinions of the use of digital tools to monitor their health. Questionnaire results were analysed descriptively and interviews using a content analysis.
Results
The device was considered both comfortable (median CRS (IQR; min-max) = 0.0 (0.0; 0-20) on a scale from 0-20 where lower scores signify better comfort) and acceptable (5.0 (0.5; 3.0-5.0) on a scale from 1-5 where higher scores signify better acceptability). Interviews showed it was easy to use, did not interfere with daily activities, and was comfortable. The following themes emerged from participants' as being important to digital technology: altered expectations for themselves, the use of technology, trust, and communication with healthcare professionals.
Conclusions
Digital tools may bridge existing communication gaps between patients and clinicians and participants are open to this. This work indicates that waist-worn devices are supported, but further work with patient advisors should be undertaken to understand some of the key issues highlighted. This will form part of the ongoing work of the Mobilise-D consortium.
Sources et attribution
Acceptability of wearable devices for measuring mobility remotely: Observations from the Mobilise-D technical validation study.
Keogh A, Alcock L, Brown P, Buckley E, Brozgol M, Gazit E, Hansen C, Scott K, Schwickert L, Becker C, Hausdorff JM, Maetzler W, Rochester L, Sharrack B, Vogiatzis I, Yarnall A, Mazzà C, Caulfield B.
Digital health · 2023-01-01
DOI: 10.1177/20552076221150745 ↗PubMed · 36756644 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

